City

Liege (1)

Shanghai (1)

Condition

Urine Marking (2)

Bladder Cancer (1)

Diagnoses Disease (1)

Effects of; Serum (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

Sponsor

Artialis (1)

Changhai Hospital (1)

Collaborator

LiSen imprinting diagnostic (LSID) Company (1)

Intervention

genomic imprinting testing (1)

serum and urine sample (1)

Study Documents

Intervention Type

diagnostic test (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Observational (2)

urine marking

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Genomic Imprinting Testing for Diagnosis of Bladder Cancer

Unknown status

Bladder Cancer
+2 more

Genomic Imprinting Testing

Shanghai, Shanghai, China

Changhai Hospital

Jun 10, 2018

Biological Variability in Cartilage Specific Biomarkers in

Completed

Effects of; Serum
Urine Marking

serum and urine sample

Liege, Belgium

ATC SA, Unité de pharmacologie clinique, CHU Sart Tilman

Jan 23, 2015